Paul, Weiss is advising Renaissance Partners, a leading investment firm based in Italy, on the English law financing aspects for its acquisition, alongside Aurora Growth Capital and the Pavese family, of Genetic S.p.A. Genetic is a leading Italian pharmaceutical contract development and manufacturing organization (CDMO) in the respiratory and ophthalmic therapeutic areas.
The Paul, Weiss team includes corporate partners Matthew Merkle, Neel Sachdev and Nicolò Ascione.
Related Insights
Finance
December 08, 2025
Bain Capital’s Ahlstrom Completes Multiple Financing Transactions
Finance
December 04, 2025